908 related articles for article (PubMed ID: 27888285)
1. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
[TBL] [Abstract][Full Text] [Related]
2. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
Hatzigeorgiou C; Jackson JL
Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
Chen L; Wang G; Zheng F; Zhao H; Li H
Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Su S; He N; Men P; Song C; Zhai S
Osteoporos Int; 2019 Jun; 30(6):1175-1186. PubMed ID: 30734066
[TBL] [Abstract][Full Text] [Related]
6. Alendronate for the Treatment of Osteoporosis in Men: A Meta-Analysis of Randomized Controlled Trials.
Xu Z
Am J Ther; 2017; 24(2):e130-e138. PubMed ID: 27058577
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk.
Nayak S; Greenspan SL
Osteoporos Int; 2019 Apr; 30(4):705-720. PubMed ID: 30623214
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials.
Liu Z; Zhang M; Shen Z; Ke J; Zhang D; Yin F
PLoS One; 2020; 15(12):e0243851. PubMed ID: 33326444
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Lou S; Lv H; Yin P; Li Z; Tang P; Wang Y
Osteoporos Int; 2019 Jan; 30(1):59-70. PubMed ID: 30539271
[TBL] [Abstract][Full Text] [Related]
10. Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis.
Abdelazim IA; Abdelrazak KM; Al-Kadi M; Yehia AH; Nusair BM; Faza MA
Arch Osteoporos; 2014; 9():189. PubMed ID: 25037077
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
Melek J; Sakuraba A
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials.
Lou S; Lv H; Li Z; Zhang L; Tang P
BMJ Open; 2018 Mar; 8(3):e015187. PubMed ID: 29500198
[TBL] [Abstract][Full Text] [Related]
13. Exercise vs Conventional Treatment for Treatment of Primary Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yan Y; Tan B; Fu F; Chen Q; Li W; Chen W; He H
Orthop Surg; 2021 Jul; 13(5):1474-1487. PubMed ID: 34124845
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
Liu H; Wang G; Wu T; Mu Y; Gu W
Front Endocrinol (Lausanne); 2022; 13():854439. PubMed ID: 35518938
[TBL] [Abstract][Full Text] [Related]
15. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
[TBL] [Abstract][Full Text] [Related]
16. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
17. Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women.
Hernández JL; Olmos JM; Romaña G; Llorca J; Martínez J; Castillo J; de Juan J; Pérez-Pajares I; Ruiz S; González-Macías J
J Clin Endocrinol Metab; 2014 Sep; 99(9):3304-9. PubMed ID: 24878047
[TBL] [Abstract][Full Text] [Related]
18. The degree of osteoporosis in patients with vertebral fracture and patients with hip fracture: relationship to incidence of vertebral fracture.
Takahashi M; Kushida K; Naitou K
J Bone Miner Metab; 1999; 17(3):187-94. PubMed ID: 10757678
[TBL] [Abstract][Full Text] [Related]
19. Effects of Teriparatide versus Salmon Calcitonin Therapy for the Treatment of Osteoporosis in Asia: A Meta-analysis of Randomized Controlled Trials.
Chen C; Alqwbani M; Zhao J; Yang R; Wang S; Pan X
Endocr Metab Immune Disord Drug Targets; 2021; 21(5):932-942. PubMed ID: 33109070
[TBL] [Abstract][Full Text] [Related]
20. Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials.
Yue J; Zhang X; Dong B; Yang M
Menopause; 2010; 17(5):1071-9. PubMed ID: 20473231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
